March 6, 2026

Opioid, ??-

Even though some drug trials, for instance on mAbs targeting EGFR, experienced limitations such as for example insufficient control arm[13], the results have already been discouraging with an just improved modestly, or even shortened sometimes, OS[13, 27, 51, 52, 56]
3 min read

Even though some drug trials, for instance on mAbs targeting EGFR, experienced limitations such as for example insufficient control arm[13], the results have already been discouraging with an just improved modestly, or even shortened sometimes, OS[13, 27, 51, 52, 56]

cmerp March 26, 2023
Even though some drug trials, for instance on mAbs targeting EGFR, experienced limitations such as for example...
Read More
New findings about the role of senescence in tumor biology are critically reviewed with respect to new suggestions for cancer therapy leveraging genetic and pharmacological methods to prevent senescence or to selectively kill senescent cells in tumors
3 min read

New findings about the role of senescence in tumor biology are critically reviewed with respect to new suggestions for cancer therapy leveraging genetic and pharmacological methods to prevent senescence or to selectively kill senescent cells in tumors

cmerp February 6, 2022
New findings about the role of senescence in tumor biology are critically reviewed with respect to new...
Read More

You may have missed

In sum, isolation of enteroviral antigens from diabetic individuals, after recent onset particularly, is now a reproducible finding fairly, supporting a job for these infections in disease development
3 min read

In sum, isolation of enteroviral antigens from diabetic individuals, after recent onset particularly, is now a reproducible finding fairly, supporting a job for these infections in disease development

March 5, 2026
Transformation in antibody level following booster dosage in fingolimod-treated MS people == Based on the reduced concentrations of anti-S1RBD IgG antibodies assessed in MSFingolimod, aswell as the tips for a SARS-CoV-2 booster dose administration, a follow-up test was extracted from MSFingolimodvolunteers at least 14 days following the booster dose (T2) [median (interquartile vary); 4
3 min read

Transformation in antibody level following booster dosage in fingolimod-treated MS people == Based on the reduced concentrations of anti-S1RBD IgG antibodies assessed in MSFingolimod, aswell as the tips for a SARS-CoV-2 booster dose administration, a follow-up test was extracted from MSFingolimodvolunteers at least 14 days following the booster dose (T2) [median (interquartile vary); 4

February 7, 2026
In zEDIII-rHF-immunized mice, there is zero cephalitis or various other disease symptoms also, and minimal viral RNA was detected at seven days after ZIKV problem
4 min read

In zEDIII-rHF-immunized mice, there is zero cephalitis or various other disease symptoms also, and minimal viral RNA was detected at seven days after ZIKV problem

February 5, 2026
The cleavage is caspase dependent and is abrogated when aspartates 56 and 61 are replaced with glutamate residues
3 min read

The cleavage is caspase dependent and is abrogated when aspartates 56 and 61 are replaced with glutamate residues

February 4, 2026